Piroxicam
A to Z Drug Facts
Piroxicam |
(pihr-OX-ih-kam) |
Feldene, ![]() |
Class: Analgesic/NSAID |
Action Decreases inflammation, pain and fever, probably through inhibition of cyclooxygenase activity and prostaglandin synthesis.
Indications Treatment of acute or long-term use of rheumatoid arthritis and osteoarthritis. Unlabeled use(s): Symptomatic relief of primary dysmenorrhea, pain, sunburn, juvenile rheumatoid arthritis.
Contraindications Known allergy or hypersensitivity to aspirin, iodides or any NSAID, including piroxicam.
Rheumatoid Arthritis, Osteoarthritis
ADULTS: PO Initiate and maintain at 20 mg/day in 1 to 2 divided doses.
Alcohol: May augment risk of GI bleeding. Anticoagulants: May increase effect of anticoagulants due to decreased plasma protein binding and inhibition of platelet aggregation. May increase risk of gastric erosion and bleeding. Beta-blockers: Antihypertensive effect may be decreased. Cholestyramine: Effects of piroxicam may be decreased. Lithium: May decrease lithium clearance. Methotrexate: May increase methotrexate levels and methotrexate toxicity. Ritonivir: May increase concentrations and possibly the toxicity of piroxicam by inhibiting its metabolism.
Lab Test Interferences May prolong bleeding time. May reversibly increase BUN and serum creatinine.
CV: Edema; weight gain; CHF; alterations in BP; vasodilation; palpitations; tachycardia. CNS: Headache; malaise; dizziness; somnolence; vertigo; depression; insomnia; nervousness. DERM: Pruritus; rash; sweating; erythema; bruising; desquamation; erythema multiforme; toxic epidermal necrolysis. EENT: Tinnitus; swollen eyes; blurred vision; eye irritation; rhinitis; pharyngitis. GI: Epigastric distress; nausea; vomiting; anorexia; constipation; stomatitis; abdominal discomfort; diarrhea; flatulence; abdominal pain; indigestion; toxicity (bleeding, ulceration, perforation); heartburn; dyspepsia; anorexia. GU: Hematuria; proteinuria; increased BUN and serum creatinine; acute renal insufficiency and failure; papillary necrosis; interstitial nephritis; nephrotic syndrome; hyperkalemia; hyponatremia. HEMA: Increased bleeding time; decreased Hgb and Hct; anemia; leukopenia; eosinophilia, thrombocytopenia. HEPA: Increased liver function tests; elevated liver enzymes. RESP: Bronchospasm; laryngeal edema; dyspnea; hemoptysis; shortness of breath.
Pregnancy: Category C. Lactation: Undetermined. Children: Safety and efficacy not established. Elderly: Increased risk of adverse reactions. May require decreased dosage. Asthma: In certain patients (aspirin-allergic, nasal polyps) may precipitate asthma attacks. Cardiovascular disease: May worsen CHF and hypertension. Coagulation disorders: Increases risk of bleeding. Dermatologic effects: Combination of dermatologic/allergic signs and symptoms (ie, arthralgias, pruritus, fever, fatigue, rash including vesiculobullous reactions, exfoliative dermatitis) suggestive of serum sickness have occurred. GI effects: Serious GI toxicity can occur at any time, with or without warning symptoms. Renal disease: Drug may accumulate, increasing the risk of toxicity. In cases of advanced kidney disease, treatment with piroxicam is not recommended.
PATIENT CARE CONSIDERATIONS |
|
|
Books@Ovid
Copyright © 2003 Facts and Comparisons
David S. Tatro
A to Z Drug Facts